Partners | Companies
Dreamgenics is a company founded in 2011 that develops its activity in the field of omics technologies and bioinformatics. They perform bioinformatic analysis of NGS data using in-house developed bioinformatics tools, which gives them an important competitive advantage.
They also carry out analysis of multiplexed protein and genes panels using Luminex xMAP® and xTAG® technologies that cover more than 300 proteins and 17.000 genes in humans and other species. These technologies allow the study of biomarkers in cancer, cardiovascular diseases, immunology, neuroscience, endocrinology, etc. Panels can be configured by clients according to the particular needs of their line of research.
Their objective is to assist clinicians and researchers to understand the molecular basis of diseases and thus help these patients to benefit from the development and implementation of Precision Medicine in clinical practice.